This study is to investigate the therapeutic efficacy and side effect of venetoclax based
regimen for relapsed or refractroy T cell acute lymphoblastic leukemia.
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Collaborators:
Affiliated Hospital of Nantong University First Affiliated Hospital Bengbu Medical College Jining Medical University Northern Jiangsu Province People's Hospital Suzhou Hospital of Traditional Chinese Medicine The Second People's Hospital of Huai'an